← Back to Company DatabaseVisit Website
10x Genomics
Single-cell and spatial genomics platforms for cancer research.
PublicPleasanton, CAFounded 2012
About
10x Genomics develops instruments and reagents for single-cell and spatial genomics analysis, widely used in cancer research. Its Chromium and Visium platforms enable researchers to study tumors at single-cell resolution and map gene expression within tissue. The technology has become essential for understanding tumor heterogeneity and the tumor microenvironment.
Total Funding
$243MKey Product
Chromium single-cell and Visium spatial genomics platformsGeography
North AmericaKey Investors
Venrocka16zForesite Capital
Focus Areas
DiagnosticsData / AnalyticsDrug Discovery
Technology
Genomics / SequencingOther
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026